Channelopathies in Idiopathic Epilepsy

Neurotherapeutics

Volumn 4, Issue 2, 2007, Pages 295-304

  Heron, Sarah E ^a   Scheffer, Ingrid E ^b   Berkovic, Samuel F ^b   Dibbens, Leanne M ^a,c   Mulley, John C ^a,c  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

channelopathy; Epilepsy; ion channel; seizure

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CHOLINERGIC RECEPTOR; LAMOTRIGINE; POTASSIUM CHANNEL KCNQ2; POTASSIUM CHANNEL KCNQ3; VALPROIC ACID; VOLTAGE GATED SODIUM CHANNEL;

ALLELE; ARTICLE; CHANNELOPATHY; CHRNA2 GENE; CHRNA4 GENE; CHRNB2 GENE; CLCN2 GENE; DRUG RESPONSE; EFHC1 GENE; EPILEPSY; FRAMESHIFT MUTATION; GABRA1 GENE; GABRG2 GENE; GENE; GENE DELETION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IDIOPATHIC EPILEPSY; ION TRANSPORT; KCNQ2 GENE; KCNQ3 GENE; LGI1 GENE; MISSENSE MUTATION; MULTIGENE FAMILY; NONSENSE MUTATION; PHARMACOGENETICS; PRIORITY JOURNAL; PROTEIN DOMAIN; SCN1A GENE; SCN1B GENE; SCN2A GENE; SEIZURE;

ANIMALS; CHANNELOPATHIES; CHLORIDE CHANNELS; EPILEPSY; FAMILY HEALTH; HUMANS; RECEPTORS, CHOLINERGIC; RECEPTORS, GABA; SODIUM CHANNELS;

EID: 33947492441     PISSN: 19337213     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nurt.2007.01.009     Document Type: Article

References (111)

1. Sander J.W. The epidemiology of epilepsy revisted. Curr Opin Neurol 16 (2003) 165-170
2. Annegers J.F. The epidemiology of epilepsy. In: Wylie E. (Ed). The treatment of epilepsy: principles and practice (1996), Williams and Wilkins, Baltimore MD
3. Berkovic S.F., Howell R.A., Hay D.A., and Hopper J.L. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann Neurol 43 (1998) 435-445
4. Gardiner M. Genetics of idiopathic generalized epilepsies. Epilepsia 46 suppl 9 (2005) 15-20
5. Turnbull J., Lohi H., Kearney J.A., et al. Sacred disease secrets revealed: the genetics of human epilepsy. Hum Mol Genet 14 (2005) 2491-2500
6. Mulley J.C., Scheffer I.E., Harkin L.A., Berkovic S.F., and Dibbens L.M. Susceptibility genes for complex epilepsy. Hum Mol Genet 14 (2005) R243-R249
7. Graves T.D. Ion channels and epilepsy. QJM 99 (2006) 201-217
8. Gargus J.J. Unraveling monogenic channelopathies and their implications for complex polygenic disease. Am J Hum Genet 72 (2003) 785-803
9. Combi R., Dalpra L., Tenchini M.L., and Ferini-Strambi L. Autosomal dominant nocturnal frontal lobe epilepsy-a critical overview. J Neurol 251 (2004) 923-934
10. Scheffer I.E., Bhatia K.P., Lopes-Cendes I., et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain 118 (1995) 61-73
11. Bertrand D., Elmslie F., Hughes E., et al. The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits. Neurobiol Dis 20 (2005) 799-804
12. Aridon P., Marini C., Di Resta C., et al. Increased sensitivity of the neuronal nicotinic receptor alpha 2 subunit causes familial epilepsy with nocturnal wandering and ictal fear. Am J Hum Genet 79 (2006) 342-350
13. Rodrigues-Pinguet N., Jia L., Li M., et al. Five ADNFLE mutations reduce the Ca2+ dependence of the mammalian α4β2 acetylcholine response. J Physiol 550 (2003) 11-26
14. Rett A., and Teubel R. Neugeborenen krampfe im rahmen einer epileptisch belasten familie. Wien Klin Wochenschr 76 (1964) 609-613
15. Biervert C., Schroeder B.C., Kubisch C., et al. A potassium channel mutation in neonatal human epilepsy. Science 279 (1998) 403-406
16. Charlier C., Singh N.A., Ryan S.G., et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat Genet 18 (1998) 53-55
17. Singh N.A., Charlier C., Stauffer D., et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet 18 (1998) 25-29
18. Richards M.C., Heron S.E., Spendlove H.E., et al. Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction. J Med Genet 41 (2004) e35
19. Singh N.A., Westenkow P., Charlier C., et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions; expansion of the functional and mutational spectrum. Brain 126 (2003) 2726-2737
20. Borgatti R., Zucca C., Cavallini A., et al. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy and mental retardation. Neurology 63 (2004) 57-65
21. Claes L.R.F., Ceulemans B., Audenaert D., et al. De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology 63 (2004) 2155-2158
22. Pereira S., Roll P., Krizova J., et al. Complete loss of the cytoplasmic carboxyl terminus of the KCNQ2 potassium channel: a novel mutation in a large Czech pedigree with benign familial neonatal convulsions or other epileptic phenotypes. Epilepsia 45 (2004) 384-390
23. Tang B., Li H., Xia K., et al. A novel mutation in KCNQ2 gene causes benign familial neonatal convulsions in a Chinese family. J Neurol Sci 221 (2004) 31-34
24. Bassi M.T., Balottin U., Panzeri C., et al. Functional analysis of KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions. Neurogenetics 6 (2005) 185-193
25. Pinto D., de Haan G.J., Carton D., et al. Gene symbol: KCNQ2. Disease: benign neonatal familial convulsion. Hum Genet 117 (2005) 300
26. Schmitt B., Wohlrab G., Sander T., Steinlein O.K., and Hajnal B.L. Neonatal seizures with tonic clonic sequences and poor developmental outcome. Epilepsy Res 65 (2005) 161-168
27. de Haan G.J., Pinto D., Carton D., et al. A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years. Epilepsia 47 (2006) 851-859
28. Hunter J., Maljevic S., Shankar A., et al. Subthreshold changes of voltage-dependent activation of the Kv7.2 channel in neonatal epilepsy. Neurobiol Dis 24 (2006) 194-201
29. Zhou X., Ma A., Liu X., et al. Infantile seizures and other epileptic phenotypes in Chinese family with a missense mutation of KCNQ2. Eur J Pediatr 165 (2006) 691-695
30. Zimprich F., Ronen G.M., Stögmann W., et al. Andreas Rett and benign familial neonatal convulsions revisited. Neurology 67 (2006) 864-866
31. Dedek K., Kunath B., Kananura C., Reuner U., Jentsch T.J., and Steinlein O.K. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci U S A 98 (2001) 12272-12277
32. Li H.Y., Tang B.S., Yan X.X., et al. Clinical and mutational analysis of KCNQ3 gene in a Chinese family with benign familial neonatal convulsions. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23 (2006) 374-377
33. Schwake M., Jentsch T.J., and Friedrich T. A carboxy-terminal domain determines the subunit specificity of KCNQ K+ channel assembly. EMBO Rep 4 (2003) 76-81
34. Wen H., and Levitan I.B. Calmodulin is an auxiliary subunit of KCNQ2/3 potassium channels. J Neurosci 22 (2002) 7991-8001
35. Yus-Najera E., Santana-Castro I., and Villaroel A. The identification and characterization of a non-continuous calmodulin binding site in non-inactivating voltage-dependent KCNQ potassium channels. J Biol Chem 277 (2002) 28545-28553
36. Schroeder B.C., Kubisch C., Stein V., and Jentsch T.J. Moderate loss of function of cyclic-AMP-modulated KCNQ2/KCNQ3 K+ channel causes epilepsy. Nature 396 (1998) 687-690
37. Lerche H., Biervert C., Alekov A.K., et al. A reduced K+ current due to a novel mutation in KCNQ2 causes neonatal convulsions. Ann Neurol 46 (1999) 305-312
38. Maquat L.E. Nonsense-mediated mRNA decay in mammals. J Cell Sci 118 (2005) 1773-1776
39. Catterall W.A. A 3D view of sodium channels. Nature 409 (2001) 988-991
40. Wallace R.H., Wang D.W., Singh R., et al. Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel β1 subunit gene SCN1B. Nat Genet 19 (1998) 366-370
41. Scheffer I.E., Harkin L.A., Grinton B.E., et al. Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations. Brain 130 (2007) 100-109
42. Audenaert D., Claes L., Ceulemans, Lofgren A., Van Broekhoven C., and De Jonge P. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology 61 (2003) 854-856
43. Escayg A., MacDonald B.T., Meisler M.H., et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet 24 (2000) 343-345
44. Claes L., Del-Favero J., Ceulemans B., Lagae L., Van Broeckhoven C., and De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 68 (2001) 1327-1332
45. Mulley J.C., Scheffer I.E., Petrou S., Dibbens L.M., Berkovic S.F., and Harkin L.A. SCN1A mutations and epilepsy. Hum Mutat 25 (2005) 535-542
46. Mantegazza M., Gambardella A., Rusconi R., et al. Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures. Proc Natl Acad Sci U S A 102 (2005) 18177-18182
47. Scheffer I.E., and Berkovic S.F. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120 (1997) 479-490
48. Depienne C., Arzimanoglou A., Trouillard O., et al. Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum Mutat 27 (2006) 389
49. Gennaro E., Santorelli F.M., Bertini E., et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem Biophys Res Commun 341 (2006) 489-493
50. Marini C., Mei D., Cross J.H., and Guerrini R. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia 47 (2006) 1737-1740
51. Morimoto M., Mazaki E., Nishimura A., et al. SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia 47 (2006) 1732-1736
52. Madia F., Striano P., Gennaro E., et al. Cryptic chromosome deletions involving SCN1A in severe myoclonic epilepsy of infancy. Neurology 67 (2006) 1230-1235
53. Mulley J.C., Nelson P., Guerrero S., et al. A new molecular mechanism for severe myoclonic epilepsy of infancy: exonic deletions in SCN1A. Neurology 67 (2006) 1094-1095
54. Suls A., Claeys K.G., Goossens D., et al. Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients. Hum Mutat 27 (2006) 914-920
55. Pereira S., Vieira J.P., Barroca F., et al. Severe epilepsy, retardation and dysmorphic features with a 2q deletion including SCN1A and SCN2A. Neurology 63 (2004) 191-192
56. Berkovic S.F., Harkin L., McMahon J.M., et al. De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. Lancet Neurol 5 (2006) 488-492
57. Yu F.H., Mantegazza M., Westenbroek R.E., et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9 (2006) 1142-1149
58. Kaplan R.E., and Lacey D.J. Benign familial neonatal-infantile seizures. Am J Med Genet 16 (1983) 595-599
59. Heron S.E., Crossland K.M., Andermann E., et al. Sodium-channel defects in benign familial neonatal-infantile seizures. Lancet 360 (2002) 851-852
60. Berkovic S.F., Heron S.E., Giordano L., et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann Neurol 55 (2004) 550-557
61. Striano P., Bordo L., Lispi M.L., et al. A novel SCN2A mutation in family with benign familial infantile seizures. Epilepsia 47 (2006) 218-220
62. Scalmani P., Rusconi R., Armatura E., et al. Effects in neocortical neurons of mutations of the Nav1.2 Na+ channel causing benign familial neonatal-infantile seizures. J Neurosci 26 (2006) 10100-10109
63. Ito M., Shirasaka Y., Hirose S., Sugawara T., and Yamakawa K. Seizure phenotypes of a family with missense mutations in SCN2A. Pediatr Neurol 31 (2004) 150-152
64. Baulac S., Huberfeld G., Gourfinkel-An I., et al. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat Genet 28 (2001) 46-48
65. Wallace R.H., Marini C., Petrou S., et al. Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet 28 (2001) 49-52
66. Cossette P., Liu L., Brisebois K., et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat Genet 31 (2002) 184-189
67. Kananura C., Haug K., Sander T., et al. A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol 59 (2002) 1137-1141
68. Audenaert D., Schwartz E., Claeys K.G., et al. A novel GABRG2 mutation associated with febrile seizures. Neurology 67 (2006) 687-690
69. Maljevic S., Krampfl K., Cobilanschi J., et al. A mutation in the GABAA receptor α1-subunit is associated with absence epilepsy. Ann Neurol 59 (2006) 983-987
70. Haug K., Warnstedt M., Alekov A.K., et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat Genet 33 (2003) 527-532
71. Kalachikov S., Evgrafov O., Ross B., et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat Genet 30 (2002) 335-341
72. Bisulli F., Tinuper P., Scudellaro E., et al. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann Neurol 56 (2004) 455-456
73. Schulte U., Thumfart J.O., Klocker N., et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvβ1. Neuron 49 (2006) 697-706
74. Suzuki T., Delgado-Escueta A.V., Aguan K., et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet 36 (2004) 842-849
75. Ma S., Blair M.A., Abou-Khalil B., Lagrange A.H., Gurnett C.A., and Hedera P. Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy. Epilepsy Res 71 (2006) 129-134
76. Kors E.E., Melberg A., Vanmolkot K.R., et al. Childhood epilepsy, familial hemiplegic migraine, cerebellar ataxia, and a new CACNA1A mutation. Neurology 63 (2004) 1136-1137
77. Vanmolkot K.R., Kors E.E., Hottenga J.J., et al. Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions. Ann Neurol 54 (2003) 360-366
78. Dichgans M., Freilinger T., Eckstein G., et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 366 (2005) 371-377
79. Tan N.C.K., Mulley J.C., and Scheffer I.E. Genetic dissection of the common epilepsies. Curr Opin Neurol 19 (2006) 157-163
80. Dibbens L.M., Heron S.E., and Mulley J.C. A polygenic heterogeneity model for complex epilepsy?. Genes Brain Behav (2007) (in press)
81. Tan N.C.K., Mulley J.C., and Berkovic S.F. Genetic association studies in epilepsy: "the truth is out there". Epilepsia 45 (2004) 1429-1442
82. Chen Y., Lu J., Pan H., et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol 54 (2003) 239-243
83. Heron S.E., Phillips H.A., Mulley J.C., et al. Genetic variation of CACNA1H in idiopathic generalized epilepsy. Ann Neurol 55 (2004) 595-596
84. Khosravani H., Altier C., Simms B., et al. Gating effects of mutations in the Cav3.2 T-type calcium channel associated with childhood absence epilepsy. J Biol Chem 279 (2004) 9681-9684
85. Khosravani H., Bladen C., Parker D.B., et al. Effects of Cav3.2 channel mutations linked to idiopathic generalized epilepsy. Ann Neurol 57 (2005) 745-749
86. Vitko I., Chen Y., Arias J.M., Shen Y., Wu X.R., and Perez-Reyes E. Functional characterization and neuronal modeling of the effects of childhood absence epilepsy variants of CACNA1H, a T-type calcium channel. J Neurosci 25 (2005) 4844-4855
87. Peloquin J.B., Khosravani H., Barr W., et al. Functional analysis of Cav3.2 T-type calcium channel mutations linked to childhood absence epilepsy. Epilepsia 47 (2006) 655-658
88. Khosravani H., and Zamponi G.W. Voltage-gated calcium channels and idiopathic generalized epilepsies. Physiol Rev 86 (2006) 941-966
89. Dibbens L.M., Feng H.J., Richards M.C., et al. GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet 13 (2004) 1315-1319
90. A receptors. J Neurosci 26 (2006) 1499-1506
91. Farrant M., and Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat Rev Neurosci 6 (2005) 215-229
92. Lenzen K.P., Heils A., Lorenz S., Hempelmann A., and Sander T. Association analysis of the Arg220His variation of the human gene encoding the GABA δ subunit with idiopathic generalized epilepsy. Epilepsy Res 65 (2005) 53-57
93. Singh B., Ogiwara I., Kaneda M., et al. A Kv4.2 truncation mutation in a patient with temporal lobe epilepsy. Neurobiol Dis 24 (2006) 245-253
94. Urak L., Feucht M., Fathi N., Hornik K., and Fuchs K. A GABRB3 promoter haplotype associated with childhood absence epilepsy impairs transcriptional activity. Hum Mol Genet 15 (2006) 2533-2541
95. Steinlein O.K., Mulley J.C., Propping P., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 11 (1995) 201-203
96. Phillips H.A., Favre I., Kirkpatrick M., et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am J Hum Genet 68 (2001) 225-231
97. Wallace R.H., Hodgson B.L., Grinton B.E., et al. Sodium channel α1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms. Neurology 61 (2003) 765-769
98. Nabbout R., Gennaro E., Dalla Bernardina B., et al. Spectrum of SCN1A mutations in severe myoclonic epilepsy of infancy. Neurology 60 (2003) 1961-1967
99. Wallace R.H., Scheffer I.E., Parasivam G., et al. Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B. Neurology 58 (2002) 1426-1429
100. Harkin L.A., Bowser D.N., Dibbens L.M., et al. Truncation of the GABAA-receptor γ2 subunit in a family with generalized epilepsy with febrile seizures plus. Am J Hum Genet 70 (2002) 530-536
101. Loscher W. Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23 (2002) 113-118
102. Rogawski M.A., and Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 5 (2004) 553-564
103. Yogeeswari P., Ragavendran J.V., Thirumurugan R., Saxena A., and Sriram D. Ion channels as important targets for antiepileptic drug design. Curr Drug Targets 5 (2004) 589-602
104. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
105. Berkovic S.F. Treatment with anti-epileptic drugs. Aust Fam Physician 34 (2005) 1017-1020
106. Benbadis S.R. Practical management issues for idiopathic generalized epilepsies. Epilepsia S9 (2005) 125-132
107. Camfield C., and Camfield P. Management guidelines for children with idiopathic generalized epilepsy. Epilepsia S9 (2005) 112-116
108. Chiron C., Marchand M.C., Tran A., et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomized placebo-controlled syndrome-dedicated trial. Lancet 356 (2000) 1638-1642
109. Guerrini R., Dravet C., and Genton P. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia 39 (1998) 508-512
110. Tan N.C.K., and Berkovic S.F. Prediction of drug resistance in epilepsy: not as easy as ABC. Lancet Neurol 5 (2006) 641-642
111. Szoeke C.E.I., Newton M., Wood J.M., et al. Update on pharmacogenetics in epilepsy; a brief review. Lancet Neurol 5 (2006) 189-196